- Clonal anergy
Anergy is a term in immunobiology that describes a lack of reaction by the body's defense mechanisms to foreign substances, and consists of a direct induction of peripheral lymphocyte tolerance. An individual in a state of anergy often indicates that the immune system is unable to mount a normal immune response against a specific antigen, usually a self-antigen. Lymphocytes are said to be anergic when they fail to respond to their specific antigen. Anergy is one of three processes that induce tolerance induction, modifying the immune system to prevent self-destruction (the others being clonal deletion and immunoregulation).
This phenomenon was first described in B lymphocytes by Gustav Nossal and termed "Clonal Anergy." The clones of B lymphocytes in this case can still be found alive in the circulation, but are very ineffective at mounting immune responses. Later Ronald Schwartz and Marc Jenkins described a similar process operating in the T lymphocyte. Many viruses (HIV being the most extreme example) seem to exploit the immune system's use of tolerance induction to evade the immune system, though the suppression of specific antigens is done by fewer pathogens (notably Mycobacterium leprae).
At the cellular level, the term "anergy" defines the inability of an immune cell to mount a complete response against its target. In the immune system, circulating cells called lymphocytes form a primary army that defends the body against pathogenic viruses, bacteria and parasites. There are two major kinds of lymphocytes - the T lymphocyte and the B lymphocyte. Among the millions of lymphocytes in the human body, only a few actually are specific for any particular infectious agent. At the time of infection, these few cells must be recruited and allowed to multiply rapidly. This process - called "clonal expansion" - allows the body to quickly mobilise an army of clones, as and when required. This clonal army then combats the pathogen until the body is free of the infection. Following clearance of the infection, the clones that are no longer needed die away naturally.
However, a small number of the body's army of lymphocytes are able to react with proteins that are normally present in a healthy body. The clonal expansion of those cells can lead to autoimmune diseases, wherein the body attacks itself. In order to prevent this process, lymphocytes possess an intrinsic quality-control mechanism. This machinery shuts down the lymphocytes' ability to expand, if the trigger for the expansion turns out to be the body's own protein. T-cell anergy can arise when the T-cell does not receive appropriate co-stimulation in the presence of specific antigen recognition. B-cell anergy can be induced by exposure to soluble circulating antigen, and is often marked by a downregulation of surface IgM expression and partial blockade of intracellular signaling pathways.
Anergy may be taken advantage of for therapeutic uses. The immune response to grafting of transplanted organs and tissues could be minimized without weakening the entire immune system— a side effect of immunosuppressive drugs like cyclosporine. Anergy may also be used to induce activated lymphocytes to become unresponsive with autoimmune diseases like diabetes mellitus, multiple sclerosis and rheumatoid arthritis. Likewise, preventing anergy in response to a tumoral growth may help in anti-tumor responses.
The "Multitest Mérieux" or "CMI Multitest" system (Multitest IMC, Istituto Merieux Italia, Rome, Italy) has been used as a general test of the level of cellular immunity. It is an intradermal test of skin reactivity (similar to tuberculin tests) in which a control (glycerol) is used with seven antigens of bacterial or fungal origin (tetanus toxoid, tuberculin, diphtheria, streptococcus, candida, trichophyton, and proteus). In this test reactions are categorized according to the number of antigens provoking a response and the summed extent of the skin response to all seven antigens. Here anergy is defined as a region of skin reactivity of 0-1 mm, hypoergy as a reaction of 2–9 mm in response to fewer than three antigens, normoergy as a reaction of 10–39 mm or to three or more antigens, and hyperergy for a reaction of 40 mm or more.
- ^ a b Schwartz, Ronald H. (1993). "T Cell Anergy". Scientific American 269 (2): 61–71.
- ^ a b c Janeway, Charles; Travers, Paul; Walport, Mark; Shlomchik, Mark (2001). Immunobiology; Fifth Edition. New York and London: Garland Science. ISBN 0-8153-4101-6. http://www.ncbi.nlm.nih.gov/books/bv.fcgi?call=bv.View..ShowTOC&rid=imm.TOC&depth=10.
- ^ Saibil, Samuel D.; Deenick, Elissa K.; Ohashi, Pamela S. (2007). "The sound of silence: modulating anergy in T lymphocytes". Current Opinion in Immunology 19 (6): 658–664. doi:10.1016/j.coi.2007.08.005. PMID 17949964.
- ^ Müller, Nicole; Schneider, Th; Zeitz, M; Marth, Th (2001). "Whipple's disease: new aspects in pathogenesis and diagnoses". Acta Endoscopica 31: 243–253. http://documents.irevues.inist.fr/bitstream/2042/7452/1/actaend_2001_3_243-253.pdf.
- ^ Spornraft, P.; Fröschl, M.; Ring, J.; Meurer, M.; Goebel, F.-D.; Ziegler-Heitbrock, H.W.L.; Riethmüller, G.; Braun-Falco, O. (1988). "T4/T8 ratio and absolute T4 cell numbers in different clinical stages of Kaposi's sarcoma in AIDS". British Journal of Dermatology 139: 1–9. http://www.rethinkingaids.com/portals/0/TheCD/S/spo.pdf.
- ^ De Flora, S.; Grassi, C.; Carati, L. (1997). "Attenuation of influenza-like symptomatology and improvement of cell-mediated immunity with long-term N-acetylcysteine treatment". Eur Respir J 10 (7): 1535–1541. doi:10.1183/09031936.97.10071535. PMID 9230243. http://erj.ersjournals.com/cgi/reprint/10/7/1535.pdf.
- Jenkins, Marc K. (February 1992). "The role of cell division in the induction of clonal anergy". Immunology Today 13 (2): 69–73. doi:10.1016/0167-5699(92)90137-V. PMID 1349483.
Immunology: Lymphocytic adaptive immune system and complement LymphoidAntigensAntibodiesImmunity vs.
Lymphocytes Substances Complement
Wikimedia Foundation. 2010.
Look at other dictionaries:
Clonal — may refer to in Immunology Clonal deletion, a process by which B cells and T cells are deactivated before act significantly upon specific antigens Clonal selection theory, a model for how the immune system responds to infection Clonal anergy, a… … Wikipedia
Clonal deletion — is a process by which B cells and T cells are deactivated after they have expressed receptors for self antigens and before they develop into fully immunocompetent lymphocytes. It is one method of immune tolerance. References ^ Lecture 15… … Wikipedia
clonal deletion theory — a theory of immunologic tolerance to self antigens according to which â€œforbidden clonesâ€ of immunocytes, those reactive with self antigens, are eliminated on contact with antigen during fetal life. The terms â€œclonal abortion,â€ â€œclonal… … Medical dictionary
Molecular mimicry — is defined as the theoretical possibility that sequence similarities between foreign and self peptides are sufficient to result in the cross activation of autoreactive T or B cells by pathogen derived peptides. Despite the promiscuity of several… … Wikipedia
Autoimmunity — Infobox Disease Name = Autoimmunity Caption = DiseasesDB = 28805 ICD10 = ICD9 = ICD9|279.4 ICDO = OMIM = 109100 MedlinePlus = eMedicineSubj = eMedicineTopic = MeshID = D001327 Autoimmunity is the failure of an organism to recognize its own… … Wikipedia
tolerance — 1. The ability to endure or be less responsive to a stimulus, especially over a period of continued exposure. 2. The power of resisting the action of a poison or of taking a drug continuously or in large doses without injurious effects. [L.… … Medical dictionary
Superantigen — [ thumb|Figure 1. Schematic of Superantigen stimulation compared to normal antigen presentation and activation  .] Superantigens (SAgs) are secreted proteins (exotoxins) that exhibit highly potent lymphocyte transforming (mitogenic) activity… … Wikipedia
Immune tolerance — or immunological tolerance is the process by which the immune system does not attack an antigen. It can be either natural or self tolerance , in which the body does not mount an immune response to self antigens, or induced tolerance , in which … Wikipedia
Central tolerance — is the mechanism by which newly developing T cells and B cells are rendered non reactive to self. The concept of central tolerance was proposed in 1959 by Joshua Lederberg, as part of his general theory of immunity and tolerance, and is… … Wikipedia
Antibody — Immunoglobulin redirects here. For the immunoglobulin family, see Immunoglobulin superfamily. Antibodies redirects here. For the film, see Antibodies (film). Each antibody binds to a specific antigen; an interaction similar to a lock and key. An… … Wikipedia